Susan D. DeVore

Susan D. DeVore, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Elevance Health, Inc., Unum Group and Solventum Corp. In total, 17 filings cover trades dated from 27 May 2021 to 26 May 2026.

Both buying and selling appear: 1 purchase worth €322k, against 1 sale worth €432k. On balance, insiders were net sellers of €110k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 12 share grants and 3 option exercises.

On 28 May 2026 came the latest disclosure, a share grant in Unum Group. The latest purchase dates back some time: it was published 423 days ago, on 21 August 2025. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.